Search Results

CSL announced 2023 Half Year Financial Results for the period ending 31st December 2022, on Tuesday, 14th February 2023 (AEDT)

CSL announced the 2022 Half Year Financial Results for the period ending 31st December 2021, on Wednesday, 16th February 2021 (AEDT)

We announced our 2021 Half Year Financial Results on Thursday, 18th February 2021 (AEDT).

Tax positions adopted must be and financial results.

CSL, representing the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus, and CSL Vifor, relentlessly innovates to help ensure patients and people get the treatments they deserve.

We announced our 2021 Full Year Financial Results for the period ending 30th June 2021 on Wednesday, 18th August 2021 (AEST).

Tax positions adopted must be and financial results.

Rights are allocated in two tranches and vesting occurs following the disclosure of half year and full year financial results following the grant of Rights.

In addition to delivering solid improve the efficiency of our business and the way in which financial results, we made significant contributions in the we help patients.

You should read these Risk Factors along with our Annual Report for the fiscal year ending 30 June 2018 and the announcement of the Financial Results to 30 June 2018, available as described under "General Information— Documents Available for Inspection", which provide a more complete description of our business and any public announcements.